Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hepatitis B
Pharma
Sanofi bolsters adult vaccine roster with $2.2B Dynavax purchase
Following an activist investor feud earlier this year, vaccine developer Dynavax Technologies has agreed to sell itself to France’s Sanofi.
Fraiser Kansteiner
Dec 29, 2025 10:24am
Fierce Healthcare
Medical groups decry CDC's major child vaccine change
Dec 17, 2025 2:00pm
ACIP revokes universal hep B vaccine endorsement for newborns
Dec 5, 2025 2:43pm
CDC's ACIP again delays vote on newborn hepatitis B vaccines
Dec 4, 2025 4:41pm
ACIP to meet with new chair as former leader gets HHS promotion
Dec 2, 2025 10:20am
Fierce Healthcare
ACIP's vaccine guidance sows confusion, health experts say
Sep 23, 2025 3:30pm